Second hit deletion size in von Hippel–Lindau disease
- 22 December 2005
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 59 (1) , 105-110
Abstract
Von Hippel–Lindau (VHL) disease is caused by germline mutations of the VHL tumor suppressor gene. Affected individuals are predisposed to development of multiple neoplastic and preneoplastic lesions of different organs. A “second hit,” which is usually represented by deletion in the wild‐type VHL allele at 3p25, is necessary for initiation of tumor formation. The impact of the size of this deletion is thought to be critical, because other tumor suppressor genes are located nearby, but this has not yet been studied in detail. We mapped the deletion size of the “second hit” in microdissected tissue from 16 different VHL‐associated lesions from the same patient using 10 polymorphic chromosome 3 markers. We found that the deletion size is highly variable, ranging from short deletions around the VHL gene to complete loss of the chromosome 3. The deletion sizes are not correlated with the site of the germline mutation, the affected organ, or the type or biological behavior of the tumor. Even preneoplastic cystic structures may harbor entire loss of the chromosome 3, suggesting that loss of VHL gene function alone is not immediately causative for neoplastic growth, but further events, either mutations and deletions in other chromosomes or epigenetic or other than genetic phenomena, are required for tumor formation. Ann Neurol 2005Keywords
This publication has 16 references indexed in Scilit:
- Developmental effects of von Hippel–Lindau gene deficiencyAnnals of Neurology, 2004
- Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and locationHuman Mutation, 2003
- Analysis of von Hippel—Lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneityJournal of Neurosurgery, 2002
- Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndromeOncogene, 2002
- Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous systemJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Genotype–phenotype correlations in von hippel–lindau diseaseJournal of Internal Medicine, 1998
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotypeHuman Mutation, 1995
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinomaNature, 1988
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971